ISPOR Europe 2024 Home
Toggle navigation
About
News Center
Award Winners
Program
Program
Student Program
Learning Formats
Plenary Sessions
Posters
Program Committee
Digital Conference Pass
Exhibits & Sponsorship
Sponsor List
Media Partners
Exhibitor Directory
Photo Gallery
ISPOR
Europe 2024
17 - 20 November
Home
Events
Past Conferences
ISPOR Europe 2024
Program
Plenary Sessions
Session
Cost-Effectiveness Analysis of Liso-Cel in the Treatment of Patients With Refractory or Relapsed Large B-Cell Lymphoma Within 12 Months (LBCL RR≤12) Eligible for Autologous Hematopoietic Stem Cell Transplant (ASCT) in France
Nov 19, 2024, 16:00 PM
«
851
852
853
(current)
854
855
856
857
858
859
860
»